First-line sunitinib or pazopanib in metastatic renal cell carcinoma: The Canadian experience.
Can Urol Assoc J
; 11(3-4): 112-117, 2017.
Article
in En
| MEDLINE
| ID: mdl-28515811
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Can Urol Assoc J
Year:
2017
Document type:
Article
Affiliation country:
Canada
Country of publication:
Canada